• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

DVT Prevention in Stroke
AbstractPurpose of ReviewThe purpose of this review is to discuss the prevention of venous thromboembolism (VTE) in stroke patients. We discuss use of oral anticoagulation and other interventions for the prevention of VTE. A new class of medications, non-vitamin K antagonist oral anticoagulants (NOACs), have been successfully trialed for the prevention of VTE. We review the data and guidance statements for VTE prevention.Recent FindingsWarfarin and vitamin K antagonist drugs have been the mainstay of VTE prevention for decades. More recently, NOACs have become available for both stroke and systemic embolism prevention in n...
Source: Current Neurology and Neuroscience Reports - September 18, 2017 Category: Neuroscience Source Type: research

Self-Advocacy
On August 18, 2008 I went up to the office to do a load of xeroxing, throwing my bag in the back seat of the car. When I got to school, however, something was wrong. Though early in the am, it was like I was drunk, with walking wobbly and difficult. Being a compulsive, I idiotically worked for half an hour, holding on to the copying machine to steady myself. Then I drove home (second stupid act), called the health help line, where they told me to get to the ER. And don't drive! Once there, they figured I had had a stroke and put me on coumadin, a powerful blood thinner. Three days later, in the evening, a nurse wrote on my...
Source: Healthy Living - The Huffington Post - November 16, 2015 Category: Consumer Health News Source Type: news

New Watchman study reports positive data
New data from a study of Boston Scientific (NYSE:BSX)’s Watchman left atrial appendage closure device reports positive results in a study comparing it to warfarin, an anticoagulant drug treatment, in patients with nonvalvular atrial fibrillation. The 2,406-patient study, published in the Journal of the American College of Cardiology, reported a lower rate of hemorrhagic strokes, unexplained and cardiovascular death and non-procedural bleeding when compared to warfarin. “I think the fact that we now actually have some good scientific data in the field is terribly important, it has been lacking. But I think we...
Source: Mass Device - June 16, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Boston Scientific Stroke Source Type: news